Leerink Revelation Partners held a final close on its second flagship vehicle, Leerink Revelation Healthcare Fund II, at a hard cap of $227 million.
The fund, which was oversubscribed and surpassed its $200 million initial target, will make secondary investments in late-stage healthcare companies, providing liquidity solutions to firms and investors.
The San Francisco-based firm’s debut secondaries fund, Leerink Revelation Healthcare Fund I, closed on $192 million in 2015.